B-Cell Activity Predicts Response to Glatiramer Acetate and Interferon in Relapsing-Remitting Multiple Sclerosis.

Sabine TackeStefan BrauneDamiano M RovitusoTjalf ZiemssenPaul V LehmannHeidi DikowArnfin BergmannStefanie Kuerten

Published in: Neurology(R) neuroimmunology & neuroinflammation (2021)

This study provides Class II evidence that in patients with RRMS, the brain reactivity of their peripheral-blood B cells predicts clinical response to GA and IFN-β.

Keyphrases

multiple sclerosis
white matter
peripheral blood
dendritic cells
pet ct
immune response
disease activity
resting state
rheumatoid arthritis
brain injury
subarachnoid hemorrhage